NAD+ Cost in 2026: Pricing Ranges and What Drives Them

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Part of the PlexusDx Education Hub, covering longevity compounds, peptide biology, and the genetic variables behind aging-related decisions. Browse the full Peptides & Longevity library.

Cost is the first question most people ask about NAD+, and the honest answer is that there is no single price. As of April 2026, what you pay varies by program, dosing format, and whether the product is dispensed through a 503A compounding pharmacy or a brand telehealth service. This piece lays out the published cost landscape, the levers that move it, and the upstream genetic context that sits beneath any longevity-compound decision.

What NAD+ costs in 2026

NAD+ is a coenzyme discussed widely in the longevity-protocol space, and it is offered in several formats. Pricing as of April 2026 depends on whether it is dispensed through a 503A compounding pharmacy or a brand telehealth service. Typical monthly costs for compounded longevity products range from roughly $100 to $400 or more, depending on dose, format, and program. Current pricing should be verified on the relevant product page before any commitment.

What drives the price

The spread exists for concrete reasons. Format matters: an injectable, an oral, or a subscription bundle carry different costs. The dispensing pathway matters too, since compounding pharmacies and telehealth brands price differently. Program structure, including how many months are bundled, shifts the monthly figure. Because these variables stack, two people can pay very different amounts for what looks like the same compound.

Subscription and membership pricing

Many longevity products are sold on a recurring model rather than a single purchase. Some telehealth platforms and compounding pharmacies offer subscription pricing or membership discounts, and eligibility for those varies by provider. The practical takeaway is that the advertised headline price is often a subscription rate, so it is worth confirming what recurring terms actually apply before assuming a one-time cost.

Does insurance help

Coverage is the exception, not the rule. Insurance coverage for longevity-protocol compounded products is generally limited or absent as of April 2026. The narrow exception is an FDA-approved indication where the prescription matches the labeled use; most longevity uses are off-label or compounded, which insurance typically does not cover. That is why price transparency, rather than a copay, tends to define this category.

Where PlexusDx fits

PlexusDx publishes per-protocol pricing on each product page and keeps its focus upstream, on the genetic context that informs any longevity decision. You can review the Longevity Protocols collection for what is offered and start with the Precision Peptide Genetic Test to understand the biology first. Cost transparency and genetic context together turn a longevity-spend decision into an informed one rather than a guess.

The genetic layer under longevity spend

Price aside, the variable that shapes fit is your own biology. Variants in FOXO3, SIRT1, and KLOTHO influence the longevity-related pathways any such compound acts through. These are pathway-level traits; they do not predict response to a specific compound and the test is not pharmacogenomic. The Precision Peptide Genetic Test reads them across 14 pathways, 49 peptides, 150+ genetic insights, so spending decisions rest on more than a headline price.

Comparing offers without getting lost

Because NAD+ pricing shifts with format, pathway, and program, comparing two offers side by side takes a little discipline. The useful move is to normalize what you are comparing: the same format, the same monthly quantity, and the same recurring terms, so a subscription rate is not mistaken for a one-time price. Insurance rarely enters the picture for these compounds, which puts the weight on transparent published pricing rather than a copay. Reading each offer down to its assumptions keeps the comparison honest. Pairing that price literacy with an understanding of your own longevity-pathway biology means a spending decision rests on fit and clarity together, rather than on whichever headline figure a search surfaced first, which is exactly how an informed longevity choice should be made.

Frequently Asked Questions

How much does NAD+ cost per month?

Pricing as of April 2026 depends on dosing, format, and dispensing pathway. Compounded longevity products typically range from about $100 to $400 per month. Verify current pricing on the relevant product page at the time of purchase. Insurance generally does not cover these products, so published pricing is the norm.

Are there discount or subscription programs?

Some telehealth platforms and compounding pharmacies offer subscription pricing or membership discounts, though eligibility varies by provider. Confirm current programs directly on the brand or product page. PlexusDx publishes per-protocol pricing on each Longevity Protocols page, so terms can be checked before any commitment.

Will insurance cover NAD+?

Coverage for longevity-protocol compounded products is generally limited or absent as of April 2026. The exception is an FDA-approved indication where the prescription matches the labeled use. Most longevity applications are off-label or compounded, which insurance typically does not reimburse, so plan on out-of-pocket pricing.

Does genetic testing change what I pay?

No, genetic testing does not directly affect price. The Precision Peptide Genetic Test provides upstream context for protocol decisions and may help avoid spending where pathway-level biology suggests low fit. Variants in FOXO3, SIRT1, and KLOTHO are educational, not predictive of compound response or cost.

Keep reading across the PlexusDx Education Hub. Return to the education library.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.